Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Second Natures peer-reviewed study published in JMIR Formative Research (2025) compared both medications within our programme: 3 Tirzepatide (Mounjaro) cohort (209 people): 22.1% average weight loss at 12 months 95.2% achieved at least 10% weight loss 83.7% achieved at least 15% weight loss Semaglutide (Wegovy) cohort (130 people): 17.1% average weight loss at 12 months 83.1% achieved at least 10% weight loss 56.2% achieved at least 15% weight loss Both cohorts exceeded clinical trial results, suggesting that comprehensive behavioural support enhances outcomes regardless of which medication you use
JAMA Pediatrics (2018) 172(12):11912
Hormonal effects of retatrutide are real, significant in some cases, and almost entirely manageable when you know what to expect
10, e00110
Starting at a low dose and increasing gradually helps minimize initial side effects
They are not reviewed or approved by the FDA for safety or effectiveness and may be prescribed when FDA-approved alternatives are unavailable or unsuitable
US$ 26.12
US$ 22.87
US$ 26.39
US$ 21.22
US$ 21.35
US$ 20.57
US$ 26.58
US$ 26.38
